Wall Street analysts anticipate NuVasive will report earnings per share of $0.47, according to Investor Newswire.
Here are four observations:
1. NuVasive's $0.32 EPS for the period ending March 31 checked within $0.05 of Wall Street analysts' predictions.
2. Price Target Brokerage firm analysts predict NuVasive's stock will hit $63.916 on a short-term basis.
3. The highest stock estimate reached $76 and the lowest estimate was $58.
4. Zacks gave NuVasive a rating of 1.27 (with one being a "strong buy" and five being a strong sell.")